| # | Drug | Count |
|---|---|---|
| 0 | METFORMIN | 38 |
| 1 | METFORMIN ER 500 MG | 20 |
| 2 | METFORMIN ER 750 MG | 20 |
| 3 | IRON | 18 |
| 4 | METFORMIN HYDROCHLORIDE | 18 |
| 5 | METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS | 18 |
| 6 | METFORMIN HYDROCHLORIDE TABLET | 18 |
| 7 | METFORMIN HYDROCHLORIDE TABLETS | 18 |
| 8 | ERYTHROPOIETIN | 16 |
| 9 | BACLOFEN | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LACTULOSE SOLUTION USP, 10 G/15 ML | 2 | 0.0198 |
| 1 | SALSALATE | 1 | 0.0011 |
| 2 | CHOLESTERINUM | 1 | 0.0009 |
| 3 | ZIPRASIDONE | 3 | 0.0008 |
| 4 | CHLORPROMAZINE | 5 | 0.0008 |
| 5 | ERYTHROPOIETIN | 16 | 0.0008 |
| 6 | SODIUM CHLORIDE 0.65% | 1 | 0.0007 |
| 7 | IBRITUMOMAB TIUXETAN | 1 | 0.0007 |
| 8 | METHYLENE BLUE | 1 | 0.0006 |
| 9 | OLANZAPINE AND SAMIDORPHAN L-MALATE | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 20 |
| 1 | Benzodiazepine [EPC] | 18 |
| 2 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 12 |
| 3 | Anti-epileptic Agent [EPC] | 11 |
| 4 | Mood Stabilizer [EPC] | 11 |
| 5 | Loop Diuretic [EPC] | 9 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 8 |
| 7 | Proton Pump Inhibitor [EPC] | 8 |
| 8 | General Anesthetic [EPC] | 7 |
| 9 | Corticosteroid [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 1 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 2 | Antifibrinolytic Agent [EPC] | 4 | 0.0004 |
| 3 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 5 | General Anesthetic [EPC] | 7 | 0.0002 |
| 6 | Typical Antipsychotic [EPC] | 4 | 0.0002 |
| 7 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 4 | 0.0001 |
| 8 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 12 | 0.0001 |
| 9 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 1 | 0.0001 |